---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-032140"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2023-09-13T23:59:59+00:00"
generated_at: "2026-06-10T19:01:27.952847+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Avalo Therapeutics faces Nasdaq delisting over low stock price; cash $6.7M

## Summary
- Nasdaq notified Avalo of delisting due to bid price ≤ $0.10 for 10 consecutive days (Low Priced Stock Rule).
- Company to request hearing by Sept 19; considering reverse stock split to regain compliance.
- Preliminary cash and equivalents of ~$6.7M as of Sept 12, 2023.
- Raised ~$12.9M net from at-the-market offering (50.8M shares) through Sept 8; additional $1.8M from 16.1M shares after Sept 8.
- Shares outstanding: 62,870,563 as of Sept 8, 2023.

## SEC filing metadata
- accession: 0001628280-23-032140
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2023-09-13T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828023032140/0001628280-23-032140-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828023032140/avtx-20230912.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-032140
- JSON: https://secwatch.observer/filing/0001628280-23-032140.json
- Plain text: https://secwatch.observer/filing/0001628280-23-032140.txt

## Key facts
- Listing & Compliance Notices
  Avalo Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5550(b)(2), 5810(c)(3)(A), 5810(c)(3)(C), 5810(c)(3)(A)(iii)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5550(b)(2), 5810(c)(3)(A), 5810(c)(3)(C), 5810(c)(3)(A)(iii)
  source text: September 12, 2023, the Company received notice (the “September 12 Letter”) from Nasdaq that Nasdaq had determined that as of September 11, 2023, the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days triggering application of Listing Rule 5810(c)(3)(A)(iii) which states in part: if during any compliance period specified in Rule 5810(c)(3)(A), a company’s security has a closing bid price of $0.10 or less for ten consecutive trading days, the Listing Qualifications Department shall issue a Staff Delisting Determination under Rule 5810 with respect to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534120/000162828023032140/0001628280-23-032140-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.